China Automotive Systems (CAAS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for September 24, 2024, with voting on director elections and auditor ratification.
Shareholders of record as of August 5, 2024, are eligible to vote; quorum requires a majority of outstanding shares.
Proxy materials and annual report are available online; voting can be done electronically, by mail, or in person.
Voting matters and shareholder proposals
Shareholders will elect five directors for one-year terms and ratify PricewaterhouseCoopers Zhong Tian LLP as independent auditors for 2024.
Board recommends voting in favor of all nominees and auditor ratification.
Shareholder proposals for the 2025 meeting must be submitted by May 28, 2025.
Board of directors and corporate governance
Board consists of five members, with three deemed independent under Nasdaq rules.
Robert Wei Cheng Tung nominated as a new independent director; Heng Henry Lu will not stand for reelection.
Board committees (audit, compensation, nominating) are fully independent and met five times each in 2023.
Chairman and CEO roles are separated; no lead independent director due to board size and independence.
Latest events from China Automotive Systems
- Q2 sales up 15.4% to $158.6M, gross margin 18.5%, $0.80/share dividend declared.CAAS
Q2 20242 Feb 2026 - Directors and auditor re-elected; shareholders urged to stay engaged as market expands.CAAS
AGM 202420 Jan 2026 - Q3 sales up 19.4% on EPS growth, but net income down 42%; guidance raised to $630M.CAAS
Q3 202414 Jan 2026 - 2024 revenue hit $650.9M, EPS sales rose 29.9%, and a special dividend was paid.CAAS
Q4 202426 Dec 2025 - Vote on redomiciling to the Cayman Islands, changing shareholder rights and reporting.CAAS
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, stock plan extension, and auditor ratification.CAAS
Proxy Filing2 Dec 2025 - Key votes include director elections, stock option plan extension, and auditor ratification.CAAS
Proxy Filing2 Dec 2025 - EPS surged 77.8% in Q3 2025 as sales and margins improved, prompting higher full-year guidance.CAAS
Q3 202526 Nov 2025 - Q1 2025 sales up 19.9% to $167.1M, but net income down on higher costs; $700M FY guidance reaffirmed.CAAS
Q1 202526 Nov 2025